References
- Smith DS, Catalona WJ. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 1995; 45(1):70–4
- Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995; 273(4):289–94
- Cupp MR, Oesterling JE. Prostate-specific antigen, digital rectal examination, and transrectal ultrasonography: their roles in diagnosing early prostate cancer. Mayo Clin Proc 1993; 68(3):297–306
- Kramer BS, Brown ML, Prorok PC, et al. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993; 119(9): 914–23
- Dorr VJ, Williamson SK, Stephens RL. An evaluation of prostate-specific antigen as a screening test for prostate cancer. Arch Intern Med 1993; 153(22):2529–37
Selected readings
- Brawer MK. The diagnosis of prostatic carcinoma. Cancer 1993; 71 (3 Suppl):899–905
- Brawer MK. How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma. CA Cancer J Clin 1995;45(3):148–64
- Budenholzer BR. Prostate-specific antigen testing to screen for prostate cancer. J Fam Pract 1995; 41(3):270–8
- Cantor SB, Spann SJ, Volk RJ, et al. Prostate cancer screening: a decision analysis. J Fam Pract 1995; 41(1):33–41
- Carter HB. Current status of PSA in the management of prostate cancer. Adv Surg 1994; 27:81–95
- Gohagan JK, Prorok PC, Kramer BS, et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol 1994;152(5 Pt 2):1905–9
- Guess HA, Gormley GJ, Stoner E, et al. The effect of finasteride on prostate specific antigen: review of available data. J Urol 1996; 155(1):3–9
- Haid M, Rabin D, King KM, et al. Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: how effective is this diagnostic triad? J Surg Oncol 1994; 56(1):32–8
- Imai K, Ichinose Y, Kubota Y, et al. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J Urol 1995;154(3):1085–9
- Littrup PJ, Goodman AC, Mettlin CJ. The benefit and cost of prostate cancer early detection. CA Cancer J Clin 1993;43(3): 134–49
- Mandelson MT, Wagner EH, Thompson RS. PSA screening: a public health dilemma. Annu Rev Public Health 1995; 16:283–306
- Parkes C, Wald NJ, Murphy P, et al. Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ 1995; 311(7016):1340–3
- Ruckle HC, Klee GG, Oesterling JE. Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc 1994; 69(1):59–68
- Walther PJ. Prostate cancer screening: why the controversy? Surg Oncol Clin North Am 1995 Apr; 4(2):315–34
- Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice. Arch Fam Med 1995; 4(4):311–5